Biotech M&A boom broadens as billion-dollar dealmaking accelerates

The biotech sector is experiencing a surge in mergers and acquisitions, with billions of dollars being moved across both public and private companies. This trend is not just limited to high-profile deals but is affecting a broad spectrum of firms. This boom signifies a major shift in the industry, indicating confidence in growth and innovation within biotech. The increased activity suggests significant strategic moves as companies seek to expand their capabilities and market reach, underscoring the sector's dynamic and competitive landscape.